Guidance for the prevention and treatment of cancer-associated venous thromboembolism.

Khorana, Alok A; Carrier, Marc; Garcia, David A; Lee, Agnes Y Y

Khorana, Alok A; Carrier, Marc; Garcia, David A; Lee, Agnes Y Y.

Afiliação

Khorana AA; Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, 9500 Euclid Ave, R35, Cleveland, OH, 44195, USA. khorana@ccf.org.
Carrier M; Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Garcia DA; Division of Hematology, University of Washington School of Medicine, Seattle, WA, USA.
Lee AY; Department of Medicine, Thrombosis Program, University of British Columbia and Vancouver Coastal Health Authority, Vancouver, BC, Canada.

J Thromb Thrombolysis ; 41(1): 81-91, 2016 Jan.

Article em En | MEDLINE | ID: mdl-26780740

Assuntos

Anticoagulantes/uso terapêutico; Neoplasias/tratamento farmacológico; Tromboembolia Venosa/tratamento farmacológico; Administração Oral; Humanos; Guias de Prática Clínica como Assunto; Tromboembolia Venosa/etiologia

Palavras-chave

Cancer; Direct oral anticoagulants (DOAC); New oral anticoagulants (NOAC); Prevention; Risk factors; Venous thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Anticoagulantes / Neoplasias Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google